These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 28341781)

  • 21. Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies.
    Meregalli PG; Tan HL; Probst V; Koopmann TT; Tanck MW; Bhuiyan ZA; Sacher F; Kyndt F; Schott JJ; Albuisson J; Mabo P; Bezzina CR; Le Marec H; Wilde AA
    Heart Rhythm; 2009 Mar; 6(3):341-8. PubMed ID: 19251209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients.
    Smits JP; Eckardt L; Probst V; Bezzina CR; Schott JJ; Remme CA; Haverkamp W; Breithardt G; Escande D; Schulze-Bahr E; LeMarec H; Wilde AA
    J Am Coll Cardiol; 2002 Jul; 40(2):350-6. PubMed ID: 12106943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
    Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
    PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p.Y1449C SCN5A mutation associated with overlap disorder comprising conduction disease, Brugada syndrome, and atrial flutter.
    Hothi SS; Ara F; Timperley J
    J Cardiovasc Electrophysiol; 2015 Jan; 26(1):93-7. PubMed ID: 24903439
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Makarawate P; Chaosuwannakit N; Vannaprasaht S; Sahasthas D; Koo SH; Lee EJD; Tassaneeyakul W; Barajas-Martinez H; Hu D; Sawanyawisuth K
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28584071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of clinical and genetic findings on the management of young patients with Brugada syndrome.
    Andorin A; Behr ER; Denjoy I; Crotti L; Dagradi F; Jesel L; Sacher F; Petit B; Mabo P; Maltret A; Wong LC; Degand B; Bertaux G; Maury P; Dulac Y; Delasalle B; Gourraud JB; Babuty D; Blom NA; Schwartz PJ; Wilde AA; Probst V
    Heart Rhythm; 2016 Jun; 13(6):1274-82. PubMed ID: 26921764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brugada syndrome with SCN5A mutations exhibits more pronounced electrophysiological defects and more severe prognosis: A meta-analysis.
    Chen C; Tan Z; Zhu W; Fu L; Kong Q; Xiong Q; Yu J; Hong K
    Clin Genet; 2020 Jan; 97(1):198-208. PubMed ID: 30963536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct Features of Probands With Early Repolarization and Brugada Syndromes Carrying SCN5A Pathogenic Variants.
    Zhang ZH; Barajas-Martínez H; Xia H; Li B; Capra JA; Clatot J; Chen GX; Chen X; Yang B; Jiang H; Tse G; Aizawa Y; Gollob MH; Scheinman M; Antzelevitch C; Hu D
    J Am Coll Cardiol; 2021 Oct; 78(16):1603-1617. PubMed ID: 34649698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of SCN5A coding and non-coding sequences in Brugada syndrome onset: What's behind the scenes?
    Daimi H; Khelil AH; Neji A; Ben Hamda K; Maaoui S; Aranega A; Be Chibani J; Franco D
    Biomed J; 2019 Aug; 42(4):252-260. PubMed ID: 31627867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SCN5A mutation status increases the risk of major arrhythmic events in Asian populations with Brugada syndrome: systematic review and meta-analysis.
    Rattanawong P; Chenbhanich J; Mekraksakit P; Vutthikraivit W; Chongsathidkiet P; Limpruttidham N; Prasitlumkum N; Chung EH
    Ann Noninvasive Electrocardiol; 2019 Jan; 24(1):e12589. PubMed ID: 30126015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of six novel SCN5A mutations in Japanese patients with Brugada syndrome.
    Nakajima T; Kaneko Y; Saito A; Irie T; Tange S; Iso T; Kurabayashi M
    Int Heart J; 2011; 52(1):27-31. PubMed ID: 21321465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genetic and molecular basis for sodium channel-mediated Brugada syndrome].
    Barajas-Martínez H; Hu D; Antzelevitch C
    Arch Cardiol Mex; 2013; 83(4):295-302. PubMed ID: 24269159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In silico validation revealed the role of SCN5A mutations and their genotype-phenotype correlations in Brugada syndrome.
    Pham HM; Dang DP; Ta TD; Le TP; Phan DP; Trinh HA; Tran TV; Luong TLA; Nguyen HM; Bui TH; Tran TH; Ta TV; Tran VK
    Mol Genet Genomic Med; 2023 Dec; 11(12):e2263. PubMed ID: 37547970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gender difference in clinical and genetic characteristics of Brugada syndrome: SADS-TW BrS registry.
    Chen CJ; Juang JJ; Lin LY; Liu YB; Ho LT; Yu CC; Huang HC; Lin TT; Liao MC; Chen JJ; Hwang JJ; Chen WJ; Yeh SS; Yang DH; Chiang FT; Lin JL; Lai LP; Horie M;
    QJM; 2019 May; 112(5):343-350. PubMed ID: 30690642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The SCN5A Gene Is a Predictor of Phenotype Severity in Brugada Syndrome: A Comprehensive Literature Review.
    Deica AV; Paduraru LF; Paduraru DN; Andronic O
    Med Princ Pract; 2023; 32(1):1-8. PubMed ID: 36446338
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Wijeyeratne YD; Tanck MW; Mizusawa Y; Batchvarov V; Barc J; Crotti L; Bos JM; Tester DJ; Muir A; Veltmann C; Ohno S; Page SP; Galvin J; Tadros R; Muggenthaler M; Raju H; Denjoy I; Schott JJ; Gourraud JB; Skoric-Milosavljevic D; Nannenberg EA; Redon R; Papadakis M; Kyndt F; Dagradi F; Castelletti S; Torchio M; Meitinger T; Lichtner P; Ishikawa T; Wilde AAM; Takahashi K; Sharma S; Roden DM; Borggrefe MM; McKeown PP; Shimizu W; Horie M; Makita N; Aiba T; Ackerman MJ; Schwartz PJ; Probst V; Bezzina CR; Behr ER
    Circ Genom Precis Med; 2020 Dec; 13(6):e002911. PubMed ID: 33164571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction disease, and Brugada syndrome to sudden cardiac death.
    Rossenbacker T; Carroll SJ; Liu H; Kuipéri C; de Ravel TJ; Devriendt K; Carmeliet P; Kass RS; Heidbüchel H
    Heart Rhythm; 2004 Nov; 1(5):610-5. PubMed ID: 15851228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing.
    Kapplinger JD; Tester DJ; Alders M; Benito B; Berthet M; Brugada J; Brugada P; Fressart V; Guerchicoff A; Harris-Kerr C; Kamakura S; Kyndt F; Koopmann TT; Miyamoto Y; Pfeiffer R; Pollevick GD; Probst V; Zumhagen S; Vatta M; Towbin JA; Shimizu W; Schulze-Bahr E; Antzelevitch C; Salisbury BA; Guicheney P; Wilde AA; Brugada R; Schott JJ; Ackerman MJ
    Heart Rhythm; 2010 Jan; 7(1):33-46. PubMed ID: 20129283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unique clinical characteristics and SCN5A mutations in patients with Brugada syndrome in Taiwan.
    Juang JM; Tsai CT; Lin LY; Liu YB; Yu CC; Hwang JJ; Chen JJ; Chiu FC; Chen WJ; Tseng CD; Chiang FT; Yeh HM; Sherri Yeh SF; Lai LP; Lin JL
    J Formos Med Assoc; 2015 Jul; 114(7):620-6. PubMed ID: 26154754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variable Na(v)1.5 protein expression from the wild-type allele correlates with the penetrance of cardiac conduction disease in the Scn5a(+/-) mouse model.
    Leoni AL; Gavillet B; Rougier JS; Marionneau C; Probst V; Le Scouarnec S; Schott JJ; Demolombe S; Bruneval P; Huang CL; Colledge WH; Grace AA; Le Marec H; Wilde AA; Mohler PJ; Escande D; Abriel H; Charpentier F
    PLoS One; 2010 Feb; 5(2):e9298. PubMed ID: 20174578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.